Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Hematology
•
Neurology
•
Vascular Neurology
•
Neurohospitalist
What is the preferred approach to managing non-occlusive or partially occlusive venous sinus thrombosis?
Answer from: at Academic Institution
I would recommend a DOAC, particularly apixaban, with follow-up imaging in 3 months.
Comments
at Northside Hospital
Thank you, Dr. @Kirshner. If it remains stable/unc...
at Vanderbilt University Medical Center
I think this is a question for which there is no r...
11705
11721
Sign in or Register to read more
20808
Related Questions
What is the utility of a hypercoagulability workup in recurrent cryptogenic stroke, and what specific tests would you recommend?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
How long would you continue chronic transfusion therapy for adult sickle cell patients who have had a stroke?
Under what circumstances do you recommend POCUS guidance for lumbar puncture?
How do you evaluate a patient with MGUS and peripheral neuropathy?
How do you use cardiac biomarkers, if at all, in prognostication for patients with ischemic stroke?
In ischemic stroke patients with low LDL levels (<30-50 mg/dl), would you consider lowering LDL levels to lower values without concern for any side effects?
How would you approach the upfront management of a patient with acute unilateral vision loss with strong clinical risk factors for both cardioembolic stroke and GCA if an expedited MRI is not possible due to the presence of an AICD?
Do you make any dose adjustments for patients with ESKD who are on apixaban and do not otherwise meet criteria for reduced dosing?
Thank you, Dr. @Kirshner. If it remains stable/unc...
I think this is a question for which there is no r...